Health Care Benefits was Cvs Health’s largest segment in fiscal 2025, bringing in $286.71B of $769.96B (37%).
| Segment | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2017 | FY 2018 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy Consumer Wellness | $217.19B | — | $249.00B | $278.73B | ||||||||
| Health Care Benefits | $182.70B | $211.29B | $261.33B | $286.71B | ||||||||
| Pharmacy Services | — | — | — | — | ||||||||
| Revenues | — | — | — | — | ||||||||
| Health Services | $205.94B | $12.27B | $183.30B | $203.55B | ||||||||
| Retail Pharmacy | — | — | — | — | ||||||||
| Corporate/ Other | $1.06B | $902.00M | $902.00M | $968.00M | ||||||||
| Intersegment Eliminations | — | — | — | — | ||||||||
| Total | $606.89B | $224.46B | $694.53B | $769.96B |
Cvs Health brought in $769.96B from its four segments in fiscal 2025, the year ended December 31, 2025. That was up 10.9% from $694.53B in fiscal 2024. Health Care Benefits was the largest at $286.71B (37.2%), ahead of Pharmacy Consumer Wellness at $278.73B (36.2%) and Health Services at $203.55B (26.4%). The remaining segment, Corporate/ Other, brought in $968.00M.
Compared with fiscal 2024, Pharmacy Consumer Wellness grew fastest, up 11.9% to $278.73B. Every segment above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these segments grew from $606.89B to $769.96B, a compound annual growth rate of 8.3%. Health Care Benefits' share of the total rose from 30.1% to 37.2%.
As Reported was Cvs Health’s largest revenue line in fiscal 2021, bringing in $418.41B of $421.44B (99%).
| Revision of Prior Period | FY 2021 |
|---|---|
| As Reported | $418.41B |
| Adjustments | $3.03B |
| Total | $421.44B |
Cvs Health brought in $421.44B from its two revenue lines in fiscal 2021, the year ended December 31, 2021. As Reported was the largest at $418.41B (99.3%), ahead of Adjustments at $3.03B (0.7%).
Products was Cvs Health’s largest revenue line in fiscal 2016, bringing in $346.75B of $355.05B (98%).
| Products and Services | FY 2016 |
|---|---|
| Products | $346.75B |
| Premiums | $6.14B |
| Services | $2.16B |
| Total | $355.05B |
Cvs Health brought in $355.05B from its three revenue lines in fiscal 2016, the year ended December 31, 2016. Products was the largest at $346.75B (97.7%), ahead of Premiums at $6.14B (1.7%) and Services at $2.16B (0.6%).
Cvs Health (CVS) reports its revenue by segment, by revision of prior period and by products and services. In fiscal 2025, Health Care Benefits was its largest segment, bringing in $286.71B (37.2% of the total), followed by Pharmacy Consumer Wellness at $278.73B (36.2%).
Health Care Benefits was Cvs Health's largest segment in fiscal 2025, bringing in $286.71B, or 37.2% of the $769.96B total across its four segments.
As Reported was Cvs Health's largest revenue line in fiscal 2021, bringing in $418.41B, or 99.3% of the $421.44B total across its two revenue lines.
Among Cvs Health's segments that make up at least 2% of revenue, Pharmacy Consumer Wellness grew fastest in fiscal 2025, up 11.9% from $249.00B to $278.73B.
Every figure comes from Cvs Health's annual financial filings, as reported. Each line keeps the name Cvs Health gives it, and years follow its fiscal calendar.
Cvs Health's revenue by segment goes back to fiscal 2008, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.